Short answer

Peptide mass spectrometry supports identity by testing whether observed ions are consistent with the expected molecular composition. Because peptides often carry more than one charge, the instrument may show several mass-to-charge peaks for one molecule.

A report should connect those ions to an expected neutral or deconvoluted mass and explain relevant adducts, salt forms, or modifications.

Key facts

  • Mass-to-charge ratio is written as m/z and is not always the neutral molecular mass.
  • One peptide can produce a family of charge-state peaks.
  • Sodium, potassium, solvents, counterions, oxidation, and other adducts or modifications can shift observed ions.
  • Intact-mass agreement supports identity but may not locate every sequence-level difference.
  • Mass spectrometry does not replace a chromatographic purity assessment.

Expected mass versus observed m/z

An expected peptide mass is calculated from the sequence, termini, modifications, isotopic convention, and chemical form. The spectrum records ions as mass divided by charge. A doubly charged ion appears at roughly half the mass-to-charge value of a singly charged ion, with adjustments for the added charge-carrying species.

Reports should state whether values are monoisotopic, average, intact, or deconvoluted so the comparison is meaningful.

Recognize charge states and adducts

Electrospray ionization commonly produces multiple protonated charge states for peptides. Related peaks may also arise from sodium or potassium adducts, water or ammonia loss, oxidation, protecting-group remnants, counterions, or other sample chemistry. These signals are not automatically separate contaminants.

Interpretation should explain which assignments are expected and which require investigation.

Understand what intact mass can establish

Close agreement between expected and observed intact mass is useful identity evidence. However, different sequences or modifications can occasionally produce similar nominal masses, and an intact-mass result may not reveal where a change occurred.

Higher-resolution data, isotope patterns, fragmentation, peptide mapping, or comparison with a qualified standard may provide stronger discrimination when the risk or research need requires it.

Keep identity separate from purity

A mass spectrum can support the identity of detected ions, but the relative intensity of ions is influenced by ionization efficiency and instrument settings. It should not be treated as a direct HPLC purity percentage. Conversely, a strong HPLC principal peak does not identify the molecule. An informative COA states which method supports each claim.

Frequently asked questions

Why does a 2,000 Da peptide show a peak near m/z 1,001?

A doubly protonated ion carries two charges, so its m/z appears near half of the neutral mass after accounting for the added protons.

Does a matching intact mass prove the full amino-acid sequence?

It is strong supporting evidence but not always complete sequence proof. Sequence-sensitive fragmentation or peptide mapping can add discrimination.

Primary references

  1. FDA Q6A: Specifications and Identification Testing
  2. NIST Chemistry WebBook: Molecular Weight Search